MaxCyte, Inc. (MXCT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

5.03

+0.67

(+15.37%)

At close: 04:00PM EDT

5.28

+0.25

(+4.97%)

After hours:

06:11PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Simply Wall St.
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Here's Why We're Watching Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Situation
  Simply Wall St.
- We're Keeping An Eye On Pan Global Resources' (CVE:PGZ) Cash Burn Rate
  Simply Wall St.
GlobeNewswire
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GAITHERSBURG, Md., May 13, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced that, on May 10, 2022, the Compensation Committee of MaxCyte’s Board of Directors granted stock options to purchase an aggregate of 73,700 shares of MaxCyte’s c
Simply Wall St.
MaxCyte (LON:MXCT) pulls back 22% this week, but still delivers shareholders solid 28% CAGR over 3 years
MaxCyte, Inc. ( LON:MXCT ) shareholders might be concerned after seeing the share price drop 28% in the last quarter...